Currently, the conventional treatment options for T2DM mainly involve stimulating insulin secretion, reducing glucose production, and enhancing the effect of insulin on target tissues, thereby reducing blood glucose levels (Chen et al., 2022; Zhou et al., 2023). Here, INS is linked to type 2 diabetes mellitus.